Let's Talk About Lupus

LUPUS is a chronic, inflammatory, connective tissue disease that can affect the joints and many organs, including the skin, heart, lungs, kidneys, and nervous system. It can cause many different symptoms; however, not everyone with lupus has all of the symptoms. Also called SLE and systemic lupus erythematosus.

Dr. Kristin Baier is a family medicine physician who recently became board certified in obesity medicine as well.  Back about ten years ago she was diagnosed with Lupus and was experiencing all the usual symptoms.  She started focusing on a nutritional solution since she did not want to remain on medications and steroids for the rest of her life.  The first book she read suggested going vegan to solve auto immune problems and she decided to give it a try. Needless to say, after five years her symptoms had not improved and she picked up more issues along the way, including anxiety, depression, an iron deficiency and a B12 deficiency.

The conclusion of this study indicated that, "The link between insulin resistance and SLE can be explained by the chronic inflammatory state, and the consequent dyslipoproteinemia."

This points to the underlying cause of lupus (and cardiovascular disease) as being metabolic in nature and the result of chronic systemic inflammation.

Read more...

The title of the above article clearly revealed that Lupus is caused by a disruption in lipid metabolism. Read full article.

After a pier review of the studies referenced below, it was concluded that, “Taking all studies together, the circulating SLE metabolome is suggestive of reduced activity in energy-generating pathways [...]  and augmented peroxidation and inflammation.”

The bottom line here is that it is known that autoimmune symptoms result from impaired energy metabolism which goes hand in hand with alterations in the gut microbiome.

Arguably, the fastest way to resolve metabolic dysfunction is with a ketogenic diet.

REFERENCES:

Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–21.
CAS
 PubMed
 Google Scholar

Assmann N, Finlay DK. Metabolic regulation of immune responses: therapeutic opportunities. J Clin Invest. 2016;126:2031–9.
PubMed
 PubMed Central
 Google Scholar

O'Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553–65.
CAS
 PubMed
 PubMed Central
 Google Scholar

Morel L. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol. 2017;13:280–90.
CAS
 PubMed
 Google Scholar

Ouyang X, Dai Y, Wen JL, Wang LX. (1) H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus. 2011;20:1411–20.
CAS
 PubMed
 Google Scholar

Wu T, Xie C, Han J, Ye Y, Weiel J, Li Q, et al. Metabolic disturbances associated with systemic lupus erythematosus. PLoS One. 2012;7:e37210.
CAS
 PubMed
 PubMed Central
 Google Scholar

Bengtsson AA, Trygg J, Wuttge DM, Sturfelt G, Theander E, Donten M, et al. Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjogren’s syndrome and systemic sclerosis. PLoS One. 2016;11:e0159384.
PubMed
 PubMed Central
 Google Scholar

Guleria A, Pratap A, Dubey D, Rawat A, Chaurasia S, Sukesh E, et al. NMR based serum metabolomics reveals a distinctive signature in patients with lupus nephritis. Sci Rep. 2016;6:35309.
CAS
 PubMed
 PubMed Central
 Google Scholar

Yan B, Huang J, Zhang C, Hu X, Gao M, Shi A, et al. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS. Mod Rheumatol. 2016;26:914–22.
CAS
 PubMed
 Google Scholar

Shin TH, Kim H-A, Jung J-Y, Baek W-Y, Lee H-S, Park HJ, et al. Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever. Metabolomics. 2017;14.
Guleria A, Phatak S, Dubey D, Kumar S, Zanwar A, Chaurasia S, et al. NMR-based serum metabolomics reveals reprogramming of lipid dysregulation following cyclophosphamide-based induction therapy in lupus nephritis. J Proteome Res. 2018;17:2440–8.
CAS
 PubMed
 Google Scholar

Li JXX, Zhou H, Wang B, Zhang MJ, Tang FY. Metabolic profiling reveals new serum biomarkers of lupus nephritis. Lupus. 2017;26:1166–73.
CAS
 PubMed
 Google Scholar

Bellocchi C, Fernandez-Ochoa A, Montanelli G, Vigone B, Santaniello A, Quirantes-Pine R, et al. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. J Clin Med. 2019;8.
Li YLL, Deng X, Zhong L. Lipidomic and metabolomic profiling reveals novel candidate biomarkers in active systemic lupus erythematosus. Int J Clin Exp Pathol. 2019;12:857–66.
CAS
 PubMed
 PubMed Central
 Google Scholar
 

Zhang Q, Li X, Yin X, Wang H, Fu C, Wang H, et al. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus. Rheumatology (Oxford) 2020.
Kim HALH, Shin TH, Jung JY, Baek WY, Park HJ, Lee G, Paik MJ, Suh CH. Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever. Lupus. 2018;27:930–8.
CAS
 PubMed
 Google Scholar

Lee SM, Lee EM, Park JK, Jeon HS, Oh S, Hong S, et al. Metabolic biomarkers in midtrimester maternal plasma can accurately predict adverse pregnancy outcome in patients with SLE. Sci Rep. 2019;9:15169.
PubMed
 PubMed Central
 Google Scholar

Malkawi AK, Alzoubi KH, Jacob M, Matic G, Ali A, Al Faraj A, et al. Metabolomics based profiling of dexamethasone side effects in rats. Front Pharmacol. 2018;9:46.
PubMed
 PubMed Central
 Google Scholar

Bordag N, Klie S, Jurchott K, Vierheller J, Schiewe H, Albrecht V, et al. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep. 2015;5:15954.
CAS
 PubMed
 PubMed Central
 Google Scholar

Di Dalmazi G, Quinkler M, Deutschbein T, Prehn C, Rayes N, Kroiss M, et al. Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing’s syndrome. Eur J Endocrinol. 2017;177:227–37.
PubMed
Google Scholar

Gropper S SJ, Groff J. Carbohydrates. In: P A, editor. Advanced nutrition and human metabolism. Belmont: Cengage; 2009. p. 63–105.
Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids. 2009;37:1–17.
PubMed
 Google Scholar

CM NDL. Amino acid oxidation and the production of urea. In: LS, editor. Lehninger principles of biochemistry. New York: W.H. Freeman; 2013. p. 695–730.
Google Scholar

CM NDL. Lipids. In: LS, editor. Lehninger principles of biochemistry. New York: W.H. Freeman; 2013. p. 357–84.
Google Scholar

 Scavuzzi BM, Simao ANC, Iriyoda TMV, Lozovoy MAB, Stadtlober NP, Franchi Santos L, et al. Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift. Immunol Res. 2018;66:158–71.
CAS
 PubMed
 Google Scholar

 Lu L, Hu C, Zhao Y, He L, Zhou J, Li H, et al. Shotgun lipidomics revealed altered profiles of serum lipids in systemic lupus erythematosus closely associated with disease activity. Biomolecules. 2018;8.
Shah D, Mahajan N, Sah S, Nath SK, Paudyal B. Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci. 2014;21.
Frostegard J, Svenungsson E, Wu RH, Gunnarsson I, Lundberg IE, Klareskog L, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum-Us. 2005;52:192–200.
CAS
 Google Scholar

 Hage MP, Al-Badri MR, Azar ST. A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role. Ther Adv Endocrinol Metab. 2014;5:77–85.
CAS
 PubMed
 PubMed Central
 Google Scholar

 Babary H, Liu X, Ayatollahi Y, Chen XP, Doo L, Uppaluru LK, et al. Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Int J Rheum Dis. 2018;21:84–92.
CAS
 PubMed
 Google Scholar

 Durcan L, Winegar DA, Connelly MA, Otvos JD, Magder LS, Petri M. Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy. J Rheumatol. 2016;43:745–50.
CAS
 PubMed
 PubMed Central
 Google Scholar

Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, et al. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. Mol Cell Endocrinol. 2013;365:260–9.
CAS
 PubMed
 Google Scholar

Subramanian S, Trence DL. Immunosuppressive agents: effects on glucose and lipid metabolism. Endocrinol Metab Clin N Am. 2007;36:891–905 vii.
CAS
 Google Scholar

Nieto MF, Jayne DR. Con: the use of calcineurin inhibitors in the treatment of lupus nephritis. Nephrol Dial Transpl. 2016;31:1567–71.
CAS
 Google Scholar

Xu T, Holzapfel C, Dong X, Bader E, Yu Z, Prehn C, et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med. 2013;11:60.
CAS
 PubMed
 PubMed Central
 Google Scholar

Thomson NC, Chaudhuri R, Spears M, Messow CM, Jelinsky S, Miele G, et al. Arachidonic acid metabolites and enzyme transcripts in asthma are altered by cigarette smoking. Allergy. 2014;69:527–36.
CAS
 PubMed
 Google Scholar

Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639–48.
CAS
 PubMed
 PubMed Central
 Google Scholar

Strand E, Rebnord EW, Flygel MR, Lysne V, Svingen GFT, Tell GS, et al. Serum carnitine metabolites and incident type 2 diabetes mellitus in patients with suspected stable angina pectoris. J Clin Endocrinol Metab. 2018;103:1033–41.
PubMed
 Google Scholar

Drogan D, Dunn WB, Lin W, Buijsse B, Schulze MB, Langenberg C, et al. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin Chem. 2015;61:487–97.
CAS
 PubMed
 Google Scholar

Wu T, Xie G, Ni Y, Liu T, Yang M, Wei H, et al. Serum metabolite signatures of type 2 diabetes mellitus complications. J Proteome Res. 2015;14:447–56.
CAS
 PubMed
 Google Scholar

Wang TJ, Gupta DK. Metabolite profiles in heart failure: looking for unique signatures in a heterogeneous syndrome. J Am Coll Cardiol. 2015;65:1521–4.
PubMed
 Google Scholar

Dietrich S, Floegel A, Weikert C, Prehn C, Adamski J, Pischon T, et al. Identification of serum metabolites associated with incident hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Hypertension. 2016;68:471–7.
CAS
 PubMed
 Google Scholar

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis. 2018;77:855–60.
PubMed
 PubMed Central
 Google Scholar

Yacoub R, Jacob A, Wlaschin J, McGregor M, Quigg RJ, Alexander JJ. Lupus: the microbiome angle. Immunobiology. 2018;223:460–5.
CAS
 PubMed
 Google Scholar

Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359:1156–61.
CAS
 PubMed
 Google Scholar

Mu Q, Zhang H, Luo XM. SLE: another autoimmune disorder influenced by microbes and diet? Front Immunol. 2015;6:608.
PubMed
 PubMed Central
 Google Scholar

Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, et al. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus. Clin Sci (Lond). 2019;133:821–38.
CAS
 Google Scholar

Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78:947–56.
CAS
 PubMed
 PubMed Central
 Google Scholar

Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5:73.
PubMed
 PubMed Central
 Google Scholar

Gudi R, Suber J, Brown R, Johnson BM, Vasu C. Pretreatment with yeast-derived complex dietary polysaccharides suppresses gut inflammation, alters the microbiota composition, and increases immune regulatory short-chain fatty acid production in C57BL/6 mice. J Nutr. 2020;150:1291–302.
PubMed
 Google Scholar

Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676–84.
CAS
 PubMed
 PubMed Central
 Google Scholar

Rodriguez-Carrio J, Lopez P, Sanchez B, Gonzalez S, Gueimonde M, Margolles A, et al. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Front Immunol. 2017;8.
Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648.
CAS
 PubMed
 PubMed Central
 Google Scholar

Wang J, Wang Y, Zhang X, Liu JQ, Zhang QP, Zhao Y, et al. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol. 2017;8.
Liu RX, Hong J, Xu XQ, Feng Q, Zhang DY, Gu YY, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23:859.
CAS
 PubMed
 Google Scholar

Org E, Blum Y, Kasela S, Mehrabian M, Kuusisto J, Kangas AJ, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 2017;18.
Ryan PM, Patterson E, Kent RM, Stack H, O'Connor PM, Murphy K, et al. Recombinant incretin-secreting microbe improves metabolic dysfunction in high-fat diet fed rodents. Sci Rep. 2017;7:13523.
PubMed
 PubMed Central
 Google Scholar

Maukonen J, Saarela M. Human gut microbiota: does diet matter? Proc Nutr Soc. 2015;74:23–36.
CAS
 PubMed
 Google Scholar

Caesar R, Fak F, Backhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med. 2010;268:320–8.
CAS
 PubMed
 Google Scholar

Floegel A, von Ruesten A, Drogan D, Schulze MB, Prehn C, Adamski J, et al. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam. Eur J Clin Nutr. 2013;67:1100–8.
CAS
 PubMed
 Google Scholar

Akbaraly T, Wurtz P, Singh-Manoux A, Shipley MJ, Haapakoski R, Lehto M, et al. Association of circulating metabolites with healthy diet and risk of cardiovascular disease: analysis of two cohort studies. Sci Rep. 2018;8:8620.
PubMed
 PubMed Central
 Google Scholar

Rebholz CM, Zheng Z, Grams ME, Appel LJ, Sarnak MJ, Inker LA, et al. Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial. Am J Clin Nutr. 2019;109:517–25.
PubMed
 PubMed Central
 Google Scholar

Perl A, Hanczko R, Lai ZW, Oaks Z, Kelly R, Borsuk R, et al. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics. 2015;11:1157–74.
CAS
 PubMed
 PubMed Central
 Google Scholar

Sipka SSS, Szucs K, Kovács I, Kiss E, Antal-Szamás P, Lakos G, Aleksza M, Illés A, Gergely P, Szegedi G. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus. J Rheumatol. 2001;28:2012–7.
CAS
 PubMed
 Google Scholar

Coras R, Murillo-Saich JD, Guma M. Circulating pro- and anti-inflammatory metabolites and its potential role in rheumatoid arthritis pathogenesis. Cells. 2020;9.
Narasimhan R, Coras R, Rosenthal SB, Sweeney SR, Lodi A, Tiziani S, et al. Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis. Arthritis Res Ther. 2018;20:164.
PubMed
 PubMed Central
 Google Scholar

Anderson JR, Chokesuwattanaskul S, Phelan MM, Welting TJM, Lian LY, Peffers MJ, et al. (1) H NMR metabolomics identifies underlying inflammatory pathology in osteoarthritis and rheumatoid arthritis synovial joints. J Proteome Res. 2018;17:3780–90.
CAS
 PubMed
 PubMed Central
 Google Scholar

Kageyama G, Saegusa J, Irino Y, Tanaka S, Tsuda K, Takahashi S, et al. Metabolomics analysis of saliva from patients with primary Sjogren’s syndrome. Clin Exp Immunol. 2015;182:149–53.
CAS
 PubMed
 PubMed Central
 Google Scholar

Fernandez-Ochoa A, Brunius C, Borras-Linares I, Quirantes-Pine R, Cadiz-Gurrea ML, Precisesads Clinical C, et al. Metabolic disturbances in urinary and plasma samples from seven different systemic autoimmune diseases detected by HPLC-ESI-QTOF-MS. J Proteome Res 2020.
Carlson AKRR, Wallace CW, Adams E, Greenwood MC, Bothner B, June RK. Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers. Clin Exp Rheumatol. 2019;37:393–9.
PubMed
 Google Scholar

Fernandez-Ochoa A, Borras-Linares I, Quirantes-Pine R, Alarcon-Riquelme ME, Beretta L, Segura-Carretero A, et al. Discovering new metabolite alterations in primary Sjogren’s syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology. J Pharm Biomed Anal. 2020;179:112999.
CAS
 PubMed
 Google Scholar

Souto-Carneiro M, Toth L, Behnisch R, Urbach K, Klika KD, Carvalho RA, et al. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis. Ann Rheum Dis. 2020;79:499–506.
PubMed
 PubMed Central
 Google Scholar